MedPath

Anal Fistula Plug Versus Endorectal Advancement Flap

Not Applicable
Conditions
Anal Fistula
Registration Number
NCT01931371
Lead Sponsor
University of Zurich
Brief Summary

The purpose of this study is to determine whether anal fistula plug or endorectal advancement flap is more successful in the treatment of anal fistulas and compared both procedures with regards to cost.

Detailed Description

A detailed analysis will be performed to determine independent predicting factors of recurrence and of higher costs.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
71
Inclusion Criteria
  • Adults (18 years of age or more)
  • Single anal fistula
  • Surgically treated with anal fistula plug or endorectal advancement flap
Exclusion Criteria
  • Children or adolescents
  • Pregnancy
  • Patients treated with setons alone

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Anal fistula recurrence rateOne year
Secondary Outcome Measures
NameTimeMethod
Independent factors predicting higher costsOne year

Multivariate analysis of parameters derived from patient demographics and characteristics, surgical procedure, and perioperative management.

Cost3 days

In-hospital costs. Typically 1 to 3 days of hospitalization

Complication rate3 days

Classified according to the Clavien-Dindo Classification of Surgical Complications.

Independent factors predicting fistula recurrenceOne year

Multivariate analysis of parameters derived from patient demographics and characteristics, surgical procedure, and perioperative management.

Length of hospital stay3 days

Typically 1 to 3 days of hospitalization.

Trial Locations

Locations (1)

University Hospital Zurich

🇨🇭

Zurich, Switzerland

University Hospital Zurich
🇨🇭Zurich, Switzerland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.